Holen Sie sich die Stockscreener-App
84.79
1.04%
0.87
Handel nachbörslich:
84.60
-0.19
-0.22%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$83.92
Offen:
$83.275
24-Stunden-Volumen:
10.75M
Relative Volume:
0.89
Marktkapitalisierung:
$211.79B
Einnahmen:
$63.43B
Nettoeinkommen (Verlust:
$16.42B
KGV:
13.07
EPS:
6.4861
Netto-Cashflow:
$14.72B
1W Leistung:
-1.40%
1M Leistung:
+4.50%
6M Leistung:
+8.71%
1J Leistung:
-22.74%
1-Tages-Spanne:
$83.16
$84.89
1-Wochen-Bereich:
$83.16
$86.46
52-Wochen-Spanne:
$73.31
$109.92
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
84.79 | 209.61B | 63.43B | 16.42B | 14.72B | 6.4861 |
|
LLY
Lilly Eli Co
|
802.83 | 734.54B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
193.22 | 462.69B | 92.15B | 25.12B | 18.18B | 10.36 |
|
ABBV
Abbvie Inc
|
229.57 | 400.78B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
131.43 | 253.15B | 53.40B | 13.68B | 16.89B | 6.8864 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Bank of America Securities Reduces PT on Merck & Co., Inc. (MRK), Keeps a Buy Rating - Insider Monkey
Merck & Co., Inc. $MRK Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat
Easterly Investment Partners LLC Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Arista Wealth Management LLC Makes New $861,000 Investment in Merck & Co., Inc. $MRK - MarketBeat
Vectors Research Management LLC Has $217,000 Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Increased by Applied Finance Capital Management LLC - MarketBeat
Stratos Investment Management LLC Has $9.52 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Nordea Investment Management AB Purchases 1,319,358 Shares of Merck & Co., Inc. $MRK - MarketBeat
Praxis Investment Management Inc. Sells 3,340 Shares of Merck & Co., Inc. $MRK - MarketBeat
WealthPlan Investment Management LLC Purchases Shares of 13,893 Merck & Co., Inc. $MRK - MarketBeat
Ritholtz Wealth Management Sells 14,311 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Keeps Eyes On Two Late-Stage Drugs In Ophthalmology - insights.citeline.com
UK Finance Minister Seeks More Pharma InvestmentAstraZeneca (NASDAQ:AZN), Merck & Co (NYSE:MRK) - Benzinga
Merck's Keytruda Plus Chemo Regimen Shows Overall Survival Benefit In Recurrent Ovarian Cancer Patients - Benzinga
Is Recursion Pharmaceuticals a Millionaire Maker? - The Motley Fool
Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now? - Yahoo Finance
Merck & Co., Inc. $MRK Shares Acquired by Turtle Creek Wealth Advisors LLC - MarketBeat
Merck: Earnings Outlook Steady, Keytruda Now Has Some Breathing Room - Seeking Alpha
S Bank Fund Management Ltd Trims Position in Merck & Co., Inc. $MRK - MarketBeat
Aware Super Pty Ltd as trustee of Aware Super Buys 156,788 Shares of Merck & Co., Inc. $MRK - MarketBeat
Patten & Patten Inc. TN Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
New York State Teachers Retirement System Buys 3,612 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Deroy & Devereaux Private Investment Counsel Inc. - MarketBeat
Allspring Global Investments Holdings LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Citi Raises Price Target on Merck (MRK), Citing Strong Pipeline and Oncology Strength - Insider Monkey
Merck: A Golden Buying Opportunity (NYSE:MRK) - Seeking Alpha
Merck's New HIV Treatment Works As Well As Top Drug In Late Trials - Benzinga
Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection - FinancialContent
Generali Asset Management SPA SGR Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
AEGON ASSET MANAGEMENT UK Plc Acquires 91,199 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Position Trimmed by Sagespring Wealth Partners LLC - MarketBeat
TD Asset Management Inc Sells 240,683 Shares of Merck & Co., Inc. $MRK - MarketBeat
Envestnet Portfolio Solutions Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Boston Trust Walden Corp Purchases 37,557 Shares of Merck & Co., Inc. $MRK - MarketBeat
Courier Capital LLC Sells 8,424 Shares of Merck & Co., Inc. $MRK - MarketBeat
Wilmington Savings Fund Society FSB Trims Position in Merck & Co., Inc. $MRK - MarketBeat
Morningstar Investment Management LLC Acquires Shares of 10,924 Merck & Co., Inc. $MRK - MarketBeat
Vest Financial LLC Buys 20,838 Shares of Merck & Co., Inc. $MRK - MarketBeat
Atria Wealth Solutions Inc. Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Pzena Investment Management LLC Buys New Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by MGO One Seven LLC - MarketBeat
Merck & Co. Earnings Preview: What to Expect - MSN
Merck & Co. Earnings Preview: What To Expect - Barchart.com
Merck: An Undervalued Stock In An Expensive Market - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Coverage Initiated by Analysts at Citigroup - MarketBeat
Almanack Investment Partners LLC. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
NorthRock Partners LLC Buys 6,614 Shares of Merck & Co., Inc. $MRK - MarketBeat
Verdence Capital Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by MOKAN Wealth Management Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Leith Wheeler Investment Counsel Ltd. - MarketBeat
Sequoia Financial Advisors LLC Has $23.68 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.07%
1.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):